post-induction hypotension
Conditions
Interventions
Propofol group:Intravenous bolus of propofol 2.0 mg/kg, sufentanil 0.4 micrograms/kg, and rocuronium bromide 0.8 mg/kg
Propofol combined with remimazolam besylate group:Intravenous bolus of remimazolam besylate 0.2 mg/kg, propofol 1.0 mg/kg, sufentanil 0.4 µg/kg, and rocuronium bromide 0.8 mg/kg were administered
Remimazolam besylate group:Intravenous remimazolam besylate 0.4 mg/kg, sufentanil 0.4 micrograms/kg, and rocuronium bromide 0.8 mg/kg
Sponsors
Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University
Eligibility
Sex/Gender
Female
Age
19 Years to 65 Years
Inclusion criteria
Inclusion criteria: Gynecologic laparoscopic surgery patients under elective general anesthesia endotracheal intubation, ASA grade I or II, age 19~65 years old
Exclusion criteria
Exclusion criteria: Participated in other clinical trials at the same time, refused to participate in this trial, body mass index (BMI) >35, surgery for normal pregnant women, allergy to lipid emulsion or remimazolam besylate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Bispectral index;Mortality within 30 days; | — |
Countries
China
Contacts
Public ContactZhao Xinmin
Yancheng Maternal and Child Health Care Hospital Affiliated to Yangzhou University
Outcome results
None listed